356 related articles for article (PubMed ID: 17163758)
1. Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate.
Takeuchi T; Kosuge M; Tadokoro A; Sugiura Y; Nishi M; Kawata M; Sakai N; Matile S; Futaki S
ACS Chem Biol; 2006 Jun; 1(5):299-303. PubMed ID: 17163758
[TBL] [Abstract][Full Text] [Related]
2. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).
Takayama K; Nakase I; Michiue H; Takeuchi T; Tomizawa K; Matsui H; Futaki S
J Control Release; 2009 Sep; 138(2):128-33. PubMed ID: 19465072
[TBL] [Abstract][Full Text] [Related]
3. A protein transduction method using oligo-arginine (3R) for the delivery of transcription factors into cell nuclei.
Hitsuda T; Michiue H; Kitamatsu M; Fujimura A; Wang F; Yamamoto T; Han XJ; Tazawa H; Uneda A; Ohmori I; Nishiki T; Tomizawa K; Matsui H
Biomaterials; 2012 Jun; 33(18):4665-72. PubMed ID: 22465335
[TBL] [Abstract][Full Text] [Related]
4. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.
Nakase I; Takeuchi T; Tanaka G; Futaki S
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):598-607. PubMed ID: 18045727
[TBL] [Abstract][Full Text] [Related]
5. Membrane permeability commonly shared among arginine-rich peptides.
Futaki S; Goto S; Sugiura Y
J Mol Recognit; 2003; 16(5):260-4. PubMed ID: 14523938
[TBL] [Abstract][Full Text] [Related]
6. Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms.
Futaki S
Biopolymers; 2006; 84(3):241-9. PubMed ID: 16333858
[TBL] [Abstract][Full Text] [Related]
7. Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates.
Shiraishi T; Nielsen PE
FEBS Lett; 2006 Feb; 580(5):1451-6. PubMed ID: 16460737
[TBL] [Abstract][Full Text] [Related]
8. Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate.
Guterstam P; Madani F; Hirose H; Takeuchi T; Futaki S; El Andaloussi S; Gräslund A; Langel U
Biochim Biophys Acta; 2009 Dec; 1788(12):2509-17. PubMed ID: 19796627
[TBL] [Abstract][Full Text] [Related]
9. Arginine carrier peptide bearing Ni(II) chelator to promote cellular uptake of histidine-tagged proteins.
Futaki S; Niwa M; Nakase I; Tadokoro A; Zhang Y; Nagaoka M; Wakako N; Sugiura Y
Bioconjug Chem; 2004; 15(3):475-81. PubMed ID: 15149174
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
[TBL] [Abstract][Full Text] [Related]
11. Proline-rich, amphipathic cell-penetrating peptides.
Pujals S; Giralt E
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):473-84. PubMed ID: 18187229
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptides for drug delivery across membrane barriers.
Foged C; Nielsen HM
Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
[TBL] [Abstract][Full Text] [Related]
13. Effects of pyrenebutyrate on the translocation of arginine-rich cell-penetrating peptides through artificial membranes: recruiting peptides to the membranes, dissipating liquid-ordered phases, and inducing curvature.
Katayama S; Nakase I; Yano Y; Murayama T; Nakata Y; Matsuzaki K; Futaki S
Biochim Biophys Acta; 2013 Sep; 1828(9):2134-42. PubMed ID: 23711826
[TBL] [Abstract][Full Text] [Related]
14. Endosome-disruptive peptides for improving cytosolic delivery of bioactive macromolecules.
Nakase I; Kobayashi S; Futaki S
Biopolymers; 2010; 94(6):763-70. PubMed ID: 20564044
[TBL] [Abstract][Full Text] [Related]
15. Amphipathic peptides and drug delivery.
Fernández-Carneado J; Kogan MJ; Pujals S; Giralt E
Biopolymers; 2004; 76(2):196-203. PubMed ID: 15054899
[TBL] [Abstract][Full Text] [Related]
16. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD.
Watkins CL; Brennan P; Fegan C; Takayama K; Nakase I; Futaki S; Jones AT
J Control Release; 2009 Dec; 140(3):237-44. PubMed ID: 19409429
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
Massodi I; Bidwell GL; Raucher D
J Control Release; 2005 Nov; 108(2-3):396-408. PubMed ID: 16157413
[TBL] [Abstract][Full Text] [Related]
18. Predicting cell-penetrating peptides.
Hansen M; Kilk K; Langel U
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
[TBL] [Abstract][Full Text] [Related]
19. Arginine-rich cell-penetrating peptides.
Schmidt N; Mishra A; Lai GH; Wong GC
FEBS Lett; 2010 May; 584(9):1806-13. PubMed ID: 19925791
[TBL] [Abstract][Full Text] [Related]
20. Acylation of octaarginine: Implication to the use of intracellular delivery vectors.
Katayama S; Hirose H; Takayama K; Nakase I; Futaki S
J Control Release; 2011 Jan; 149(1):29-35. PubMed ID: 20144669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
